Literature DB >> 11576757

A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis.

R Damadzic1, L B Bigelow, L S Krimer, D A Goldenson, R C Saunders, J E Kleinman, M M Herman.   

Abstract

A number of macroscopic changes have been reported in the temporal lobe in schizophrenia. We have evaluated the density of glial fibrillary acidic protein (GFAP)-positive astrocytes in cortical layers 2 through 6 in the intermediate subarea of entorhinal cortex in two cohorts: the first, 15 cases, made up of schizophrenic (n = 7) and normal nonpsychiatric control subjects (n = 8), and the second, 56 cases, composed of schizophrenic (n = 14), bipolar disorder (n = 13), major depressive (n = 14) and normal control subjects (n = 15). No significant difference in density of GFAP-positive astrocytes was detected between the psychiatric diagnostic groups and the normal controls in either of the two cohorts. In both cohorts there was a positive correlation between increasing age and astrocytic density which reached statistical significance in only the larger cohort (r = 0.38, p = 0.004). Our results find no evidence for astrocytosis in the entorhinal cortex in several mental illnesses. Although other studies have reported macroscopic and other structural abnormalities in this region, we have not detected astrocytic proliferation, which is a typical hallmark of atrophy and/or progressive neuronal loss.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576757     DOI: 10.1016/s0361-9230(01)00529-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  27 in total

Review 1.  Expression profile analysis of neurodegenerative disease: advances in specificity and resolution.

Authors:  Jason G Glanzer; Phillip G Haydon; James H Eberwine
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 2.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 3.  Searching for neuropathology: gliosis in schizophrenia.

Authors:  Tatiana P Schnieder; Andrew J Dwork
Journal:  Biol Psychiatry       Date:  2010-10-30       Impact factor: 13.382

4.  Glia mechanisms in mood regulation: a novel model of mood disorders.

Authors:  Younglim Lee; Denise Gaskins; Amit Anand; Anantha Shekhar
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 5.  What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?

Authors:  Boldizsár Czéh; Paul J Lucassen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-08       Impact factor: 5.270

Review 6.  (Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia.

Authors:  Allyson P Mallya; Ariel Y Deutch
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

7.  Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice.

Authors:  Wataru Kamitani; Etsuro Ono; Saori Yoshino; Tsutomu Kobayashi; Satoshi Taharaguchi; Byeong-Jae Lee; Makiko Yamashita; Takeshi Kobayashi; Minoru Okamoto; Hiroyuki Taniyama; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

8.  Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression.

Authors:  Xiaohong Si; Jose Javier Miguel-Hidalgo; Gillian O'Dwyer; Craig A Stockmeier; Grazyna Rajkowska
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

9.  Selection of reference gene expression in a schizophrenia brain cohort.

Authors:  Cynthia Shannon Weickert; Donna Sheedy; Debora A Rothmond; Irina Dedova; Samantha Fung; Therese Garrick; Jenny Wong; Antony J Harding; Sinthuja Sivagnanansundaram; Clare Hunt; Carlotta Duncan; Nina Sundqvist; Shan-Yuan Tsai; Jasna Anand; Daren Draganic; Clive Harper
Journal:  Aust N Z J Psychiatry       Date:  2010-01       Impact factor: 5.744

Review 10.  Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Authors:  Rodrigo D Paz; Sonia Tardito; Marco Atzori; Kuei Y Tseng
Journal:  Eur Neuropsychopharmacol       Date:  2008-07-23       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.